Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study Assessing Long-term Safety of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

NCT02553798 is registered in ClinicalTrials.gov with Journey Medical Corporation as lead sponsor.

NCT NCT02553798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study Assessing Long-term Safety of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
Lead sponsor
Journey Medical Corporation
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2015
Completion date
December 31, 2016
Enrollment
564 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhidrosis